FibroGen, Inc.

409 Illinois Street
San Francisco,  CA 
United States
  • Booth: 19


FibroGen is out to generate breakthroughs in drug discovery. The private drug development company is focused on developing and commercializing treatments for inflammatory, oncology, and autoimmune conditions. It also develops and sells recombinant human collagen and gelatin products, which are used in a number of pharmaceutical, medical, and consumer processes such as drug stabilization. FibroGen has several proprietary products in clinical development, including biotechnology (protein-based) and traditional pharmaceutical (chemical-based) candidates.